Perspectives by Leerink Partners
Perspectives by Leerink Partners
Podcast Description
Welcome to Perspectives, Leerink Partners’ signature podcast, where we share our insights and interview leaders across the industry to get their perspective on how they’re driving innovation. We’ll also be digging into the back story to learn more about what has most influenced their success. Be sure to check out all episodes by Leerink Partners.
Podcast Insights
Content Themes
The podcast explores themes such as healthcare innovation, leadership journeys, and personal stories of resilience. Episodes feature discussions on specific topics like pharmacoeconomics, healthcare equity, and the impact of technology on patient care, such as the episode addressing the needs of underserved populations in maternal health.
Welcome to Perspectives, Leerink Partners’ signature podcast, where we share our insights and interview leaders across the industry to get their perspective on how they’re driving innovation. We’ll also be digging into the back story to learn more about what has most influenced their success. Be sure to check out all episodes by Leerink Partners.
Melanie Whittington, PhD, Head of the Leerink Center for Pharmacoeconomics interviews Holly Krasa, CEO of Blue Persimmon Group. In this episode they discuss the recent CPE Exclusive: Cobenfy™ for Adults Living with Schizophrenia, the need for innovation in schizophrenia, and the importance of listening to the stories from people living with schizophrenia.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.